Use of proton pump inhibitors is associated with fractures in young adults: a population-based study

被引:81
|
作者
Freedberg, D. E. [1 ]
Haynes, K. [2 ]
Denburg, M. R. [3 ]
Zemel, B. S. [4 ]
Leonard, M. B. [5 ,6 ]
Abrams, J. A. [1 ]
Yang, Y. -X. [2 ,7 ]
机构
[1] Columbia Univ, Div Digest & Liver Dis, Med Ctr, New York, NY 10032 USA
[2] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
[6] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[7] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA
关键词
Acid suppression medications; Bone mineral density; Fracture; Histamine-2 receptor antagonists; Osteoporosis; Outcomes research; Pediatrics; Pharmacoepidemiology; Proton pump inhibitors; BONE-MINERAL DENSITY; GASTROESOPHAGEAL-REFLUX DISEASE; NETWORK THIN DATABASE; CALCIUM-ABSORPTION; RISK; CHILDREN; EPIDEMIOLOGY; VALIDATION; ACID; OSTEOPOROSIS;
D O I
10.1007/s00198-015-3168-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Summary Proton pump inhibitors (PPIs) are associated with risk for fracture in osteoporotic adults. In this population-based study, we found a significant association between PPIs and fracture in young adults, with evidence of a dose-response effect. Young adults who use PPIs should be cautioned regarding risk for fracture. Introduction Proton pump inhibitors (PPIs) are associated with fracture in adults with osteoporosis. Because PPI therapy may interfere with bone accrual and attainment of peak bone mineral density, we studied the association between use of PPIs and fracture in children and young adults. Methods We conducted a population-based, case-control study nested within records from general medical practices from 1994 to 2013. Participants were 4-29 years old with a parts per thousand yen1 year of follow-up who lacked chronic conditions associated with use of long-term acid suppression. Cases of fracture were defined as the first incident fracture at any site. Using incidence density sampling, cases were matched with up to five controls by age, sex, medical practice, and start of follow-up. PPI exposure was defined as 180 or more cumulative doses of PPIs. Conditional logistic regression was used to estimate the odds ratio and confidence interval for use of PPIs and fracture. Results We identified 124,799 cases and 605,643 controls. The adjusted odds ratio for the risk of fracture associated with PPI exposure was 1.13 (95 % CI 0.92 to 1.39) among children aged < 18 years old and 1.39 (95 % CI 1.26 to 1.53) among young adults aged 18-29 years old. In young adults but not children, we observed a dose-response effect with increased total exposure to PPIs (p for trend < 0.001). Conclusions PPI use was associated with fracture in young adults, but overall evidence did not support a PPI-fracture relationship in children. Young adults who use PPIs should be cautioned regarding potentially increased risk for fracture, even if they lack traditional fracture risk factors.
引用
收藏
页码:2501 / 2507
页数:7
相关论文
共 50 条
  • [31] Proton pump inhibitors are associated with incident type 2 diabetes mellitus in a prospective population-based cohort study
    Czarniak, Petra
    Ahmadizar, Fariba
    Hughes, Jeff
    Parsons, Richard
    Kavousi, Maryam
    Ikram, Mohammad
    Stricker, Bruno H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2718 - 2726
  • [32] Eczema is associated with osteoporosis and fractures in adults: A US population-based study
    Garg, Nitin K.
    Silverberg, Jonathan I.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (04) : 1085 - +
  • [33] Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study
    Chiu, Hui-Fen
    Huang, Ya-Wen
    Chang, Chih-Ching
    Yang, Chun-Yuh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) : 1131 - 1136
  • [34] Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study
    Chen, Chao-Hung
    Lee, Cha-Ze
    Lin, Yi-Chun
    Kao, Li-Ting
    Lin, Herng-Ching
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03) : 350 - 355
  • [35] Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies
    Yu, Elaine W.
    Bauer, Scott R.
    Bain, Paul A.
    Bauer, Douglas C.
    AMERICAN JOURNAL OF MEDICINE, 2011, 124 (06) : 519 - 526
  • [36] Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study
    Lei, Wei-Yi
    Wang, Jen-Hung
    Yi, Chih-Hsun
    Liu, Tso-Tsai
    Hung, Jui-Sheng
    Wong, Ming-Wun
    Bair, Ming-Jong
    Vaezi, Michael F.
    Orr, William C.
    Chen, Chien-Lin
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (01)
  • [37] Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis A Population-Based Cohort Study
    Tran, Tanja
    Assayag, Deborah
    Ernst, Pierre
    Suissa, Samy
    CHEST, 2021, 159 (02) : 673 - 682
  • [38] Bone density in proton pump inhibitors users: a prospective study
    Ozdil, Kamil
    Kahraman, Resul
    Sahin, Abdurrahman
    Calhan, Turan
    Gozden, Erdem H.
    Akyuz, Umit
    Erer, Burak
    Sokmen, Mehmet H.
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (09) : 2255 - 2260
  • [39] Use of proton pump inhibitors and mortality after hip fracture in a nationwide study
    Brozek, W.
    Reichardt, B.
    Zwerina, J.
    Dimai, H. P.
    Klaushofer, K.
    Zwettler, E.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (05) : 1587 - 1595
  • [40] Fracture Incidence and Characteristics in Young Adults Aged 18 to 49 Years: A Population-Based Study
    Farr, Joshua N.
    Melton, L. Joseph, III
    Achenbach, Sara J.
    Atkinson, Elizabeth J.
    Khosla, Sundeep
    Amin, Shreyasee
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (12) : 2347 - 2354